首页|期刊导航|临床与实验病理学杂志|Claudin18.2在不同类型胃腺癌样本及转移阶段表达一致性分析

Claudin18.2在不同类型胃腺癌样本及转移阶段表达一致性分析OA

Concordance of Claudin18.2 expression across specimen types and metastatic sites in gastric adenocarcinoma

中文摘要英文摘要

目的 探讨Claudin18.2在胃腺癌不同类型样本中的表达及一致性,并分析其与临床病理学特征的关系.方法 收集85例胃腺癌标本,每例均包含内镜活检标本、手术根治标本及转移淋巴结标本,其中29例包含远处转移灶标本.采用免疫组化法检测Claudin18.2表达情况,并通过Kappa一致性检验及组内相关系数(intraclass correlation coefficient,ICC)评价不同类型标本间的表达一致性,同时分析其与临床病理参数的相关性.结果 在85例胃腺癌中,Claudin18.2在活检标本、手术根治标本、转移淋巴结及远处转移灶标本中的阳性率分别为41.2%(35/85)、32.9%(28/85)、31.8%(27/85)和44.8%(13/29).43.6%病例显示活检标本与手术根治标本的Claudin18.2表达存在异质性.一致性分析显示,手术根治标本与活检标本间的Kappa值为0.775(95%CI:0.64~0.91)(P<0.001),与转移淋巴结标本间的Kappa值为0.812(95%CI:0.68~0.95)(P<0.001),三类标本的单一度量ICC为0.763(95%CI:0.68~0.83).在29例伴有远处转移患者中,手术根治标本与远处转移灶标本间的Kappa值为0.649(95%CI:0.37~0.93)(P=0.001),而活检标本与远处转移灶标本间的Kappa值为0.450(95%CI:0.13~0.77)(P=0.025).相关性分析显示,Claudin18.2表达与肿瘤分化程度相关(P<0.05),而与患者年龄、性别、Lauren分型、肿瘤部位及TNM分期无明显相关性.结论 Claudin18.2在胃腺癌活检标本、手术根治标本及转移淋巴结标本中具有较高的表达一致性,而在活检标本与远处转移灶标本之间的表达一致性相对较低.

Objective To investigate Claudin18.2 expression and concordance across different gastric adenocar-cinoma specimen types and to analyze its associations with clinicopathological features.Methods Paired endoscopic biopsy,surgical resection,and metastatic lymph node specimens were retrospectively collected from 85 patients with gastric adenocarcinoma;distant metastatic specimens were also available from 29 patients.Claudin18.2 protein ex-pression was assessed by immunohistochemistry.Concordance across specimen types was evaluated using kappa statis-tics and intraclass correlation coefficients(ICCs),and associations with clinicopathological features were analyzed.Results Claudin18.2 positivity rates in biopsy,surgical resection,metastatic lymph node,and distant metastatic specimens were 41.2%(35/85),32.9%(28/85),31.8%(27/85),and 44.8%(13/29),respectively.Heterogeneous Claudin18.2 expression between biopsy and resection specimens was observed in 43.6%of cases.Kappa values were 0.775(95%CI:0.64-0.91,P<0.001)between resection and biopsy specimens and 0.812(95%CI:0.68-0.95,P<0.001)between resection and metastatic lymph node specimens.The single-measure ICC across biopsy,resection,and metastatic lymph node specimens was 0.763(95%CI:0.68-0.83).Among 29 patients with distant metastases,the kappa value was 0.649(95%CI:0.37-0.93,P=0.001)between resection and distant metastatic specimens and 0.450(95%CI:0.13-0.77,P=0.025)between biopsy and distant metastatic specimens.Claudin18.2 expression was significantly associated with tumor differentiation(P<0.05)but not with age,sex,Lauren classification,tumor lo-cation,or TNM stage.Conclusion Claudin18.2 expression showed high concordance among biopsy,surgical resec-tion,and metastatic lymph node specimens but lower concordance between biopsy and distant metastatic specimens.

赵荣荣;吴晓冰;陈兵;张凯健;付尧;樊祥山

安徽医科大学第一附属医院病理科,合肥 230022安徽医科大学第一附属医院病理科,合肥 230022安徽医科大学第一附属医院病理科,合肥 230022安徽医科大学第一附属医院病理科,合肥 230022安徽医科大学第一附属医院病理科,合肥 230022安徽医科大学第一附属医院病理科,合肥 230022

医药卫生

胃肿瘤腺癌Claudin18.2免疫组织化学表达一致性肿瘤异质性

gastric neoplasmsadenocarcinomaClaudin18.2immunohistochemistryexpression concordancetumor heterogeneity

《临床与实验病理学杂志》 2026 (8)

1002-1007,6

10.13315/j.cnki.cjcep.2026.08.004

评论